Correlation Between Deutsche Bank and In Veritas
Can any of the company-specific risk be diversified away by investing in both Deutsche Bank and In Veritas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Deutsche Bank and In Veritas into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Deutsche Bank AG and In Veritas Medical, you can compare the effects of market volatilities on Deutsche Bank and In Veritas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Deutsche Bank with a short position of In Veritas. Check out your portfolio center. Please also check ongoing floating volatility patterns of Deutsche Bank and In Veritas.
Diversification Opportunities for Deutsche Bank and In Veritas
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Deutsche and IVME is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Deutsche Bank AG and In Veritas Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on In Veritas Medical and Deutsche Bank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Deutsche Bank AG are associated (or correlated) with In Veritas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of In Veritas Medical has no effect on the direction of Deutsche Bank i.e., Deutsche Bank and In Veritas go up and down completely randomly.
Pair Corralation between Deutsche Bank and In Veritas
If you would invest 1,690 in Deutsche Bank AG on September 22, 2024 and sell it today you would earn a total of 3.00 from holding Deutsche Bank AG or generate 0.18% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 98.46% |
Values | Daily Returns |
Deutsche Bank AG vs. In Veritas Medical
Performance |
Timeline |
Deutsche Bank AG |
In Veritas Medical |
Deutsche Bank and In Veritas Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Deutsche Bank and In Veritas
The main advantage of trading using opposite Deutsche Bank and In Veritas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Deutsche Bank position performs unexpectedly, In Veritas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In Veritas will offset losses from the drop in In Veritas' long position.Deutsche Bank vs. Banco Bradesco SA | Deutsche Bank vs. Itau Unibanco Banco | Deutsche Bank vs. Banco Santander Brasil | Deutsche Bank vs. Western Alliance Bancorporation |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |